| |
| Bringing a novel therapeutic to market is a complex, time-intensive process — but partnering with the right CDMO can make all the difference. Outsourced Pharma is here to help you find the ideal collaborator for your project. The Outsourced Pharma Capacity Update (OPCU) connects you with leading CDMOs, offering real-time insights into their available capacity, services, and facility updates. This event delivers concise, informative presentations, giving you a clear snapshot of industry suppliers — all from the convenience of your desk. Over time, our PARTNER WEEK has expanded, extending the schedule and organizing sessions by capability to make it even easier to find the right outsourcing partner for your specific needs. Plus, we’ve recently introduced STREAM by Life Science Connect — a cutting-edge platform for engaging video content in the life sciences industry. With over 40,000 webinar views in 2024, STREAM meets the growing demand for video-based learning, helping you stay informed and connected like never before. Find the right development and manufacturing partner at the upcoming OPCU in April 2025. Registration is free at the links below. - Monday, April 21, 2025 - ADC
- Tuesday, April 22, 2025 (AM) - Large Molecule Drug Substance
- Tuesday, April 22, 2025 (PM) - Bioanalytical Services
- Wednesday, April 23, 2025 - Small Molecule
- Thursday, April 24, 2025 - Cell & Gene Therapy
- Friday, April 25, 2025 - Fill/Finish
|
|
| | Lonza | Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities. | Request Information | Lonza |
|
| Lifecore Biomedical | Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics. | Request Information | Lifecore Biomedical |
|
| Jubilant HollisterStier | From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision. | Request Information | Jubilant HollisterStier |
|
| Alcami | Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes. | Request Information | Alcami |
|
| Ajinomoto Bio-Pharma | This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges. | Request Information | Ajinomoto Bio-Pharma Services |
|
| | Upperton Pharma Solutions | Gain insight into the capabilities of our award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites integrated with R&D and QC laboratories. | Request Information | Upperton Pharma Solutions |
|
| Douglas CDMO | By leveraging our extensive experience, flexible capabilities, and client-focused approach, we help our partners accelerate time-to-market and achieve successful outcomes for their therapies. | Request Information | Douglas CDMO |
|
| Alcami | With cutting-edge capabilities and client-focused solutions, Alcami supports your drug development journey from concept to commercialization, helping you bring transformative therapies to patients with speed and quality. | Request Information | Alcami |
|
| Ajinomoto Bio-Pharma Services | Discover how our cutting-edge development laboratories, advanced flow chemistry units, and expanded manufacturing capacity are designed to address your most complex challenges and fulfill all your production needs. | Request Information | Ajinomoto Bio-Pharma Services |
|
| | |
| Skip the lengthy vetting process and simplify your search for the perfect CDMO partner at the April 2025 OPCU virtual event! In one day, you can connect with multiple CDMOs to find the ideal fit for your project. Register now for the event! To make it even easier, OPCU is organized by capability type, so you can register for sessions tailored to the CDMOs best suited to your company’s development and manufacturing needs. - Monday, April 21, 2025 - ADC | Free Registration
- Tuesday, April 22, 2025 (AM) - Large Molecule Drug Substance | Free Registration
- Tuesday, April 22, 2025 (PM) - Bioanalytical Services | Free Registration
- Wednesday, April 23, 2025 - Small Molecule | Free Registration
- Thursday, April 24, 2025 - Cell & Gene Therapy | Free Registration
- Friday, April 25, 2025 - Fil/Finish | Free Registration
|
|
| | | Wednesday, March 19, 2025 | New York, NY CDMOs have an opportunity to win in each category in up to three groups of outsourcing respondents — Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma). We also recognize those companies that scored one standard deviation or more above the weighted average in each of the core categories. Award recipients are honored during a ceremony, after which we enjoy great food, drink, and company. Research participants, winning CDMOs, and other industry stakeholders are invited to attend. |
|
|
|
|
